Highlights Ocumetics Technology Corp.

Equities

OTC

CA67577H1047

Market Closed - Toronto S.E. Other stock markets 17:22:51 17/05/2024 BST			5-day change	1st Jan Change
0.32 ^CAD	0.00%		-3.03%	-5.88%

05-15	Ocumetics Technology Corp. announced that it expects to receive CAD 3.76 million in funding	CI
04-11	Ocumetics Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ocumetics Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	04-10	CI
Ocumetics Technology Corp. Announces Successful Completion of Animal Study in Preparation for Its First-In-Human Study, Anticipated to Commence in First Quarter of 2024 in the Dominican Republic	12-07	CI
Ocumetics Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20	CI
Ocumetics Continues to Meet Significant Development Milestones Lens Design Optimized for Upcoming First in Human Study	18/09/23	CI
Ocumetics Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23	CI
Ocumetics Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/05/23	CI
Ocumetics Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	25/04/23	CI
Ocumetics Technology Corp. Announces Successful Completion of Animal Studies	12/02/23	CI
Ocumetics Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	17/11/22	CI
Ocumetics Technology Corp.' Lens Technology Delivers 14-Diopters of Accommodation in Bench Studies	29/08/22	CI
Ocumetics Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	19/08/22	CI
Ocumetics Technology Corp. Provides an Update on Preclinical Bench Test Results of its Lens Technologies	24/05/22	CI
Ocumetics Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	20/05/22	CI
Ocumetics Technology Corp. Provides Update on Preclinical Studies	19/05/22	CI
Ocumetics Technology Corp. Reports Earnings Results for the Five Months Ended December 31, 2021	03/05/22	CI
Ocumetics Announces Commencement of Regulatory Strategy Project with Clinical Research Consultants, Inc	03/02/22	CI
Ocumetics Technology Corp. Partners with Bioana	17/01/22	CI
Ocumetics Technology Corp. Provides Update on Preclinical Studies	12/01/22	CI
Ocumetics Technology Corp. Reports Earnings Results for the Two Months Ended September 30, 2021	29/11/21	CI
Ocumetics Technology Corp. Commences Clinical Trials for the Bionic Lens	26/10/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Ocumetics Technology Corp.

Equities

OTC

CA67577H1047

Highlights

Filters